期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Ki-67在不同类型乳腺癌中的研究进展 被引量：2

下载PDF
导出
摘要 乳腺癌是女性最常见的恶性肿瘤之一，20世纪末的统计资料表明，全世界每年均有130万人诊断为乳腺癌，而有40万人死于该病。在我国，随着社会压力及生活环境的变化，乳腺癌发病率不断上升，更有年轻化的趋势，在一些大城市已跃居肿瘤之首，
作者 刘秦香 李丽
机构地区 大连医科大学 大连医科大学附属第一医院肿瘤科
出处 《现代医药卫生》 2014年第3期379-381,共3页 Journal of Modern Medicine & Health
关键词 KI-67抗原 乳腺肿瘤 综述
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献30

  • 1Gerdes J, Schwab U, Lemke H, et al. Production of a mouse mo- noclonal antibody reactive with a human nuclear antigen associ- ated with cell proliferation[J]. Int J Cancer, 1983,31 ( 1 ) : 13-20.
  • 2MacCallum DE, Hall PA. The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle[J]. J Pathol,2000,190 (5) :537-544.
  • 3Rahmanzadeh R, Hottmann G, Gerdes J, et al. Chromophore-as- sisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis[J]. Cell prolif, 2007,40 (3) :422-430.
  • 4Kim DK, Kim DW, Kim SW, et al. Ki67 antigen as a predictive factor for prognosis of Sinonasal mucosal melanoma[J]. Clin Exp Otorhinolaryngo, 2008,1 (4) : 206-210.
  • 5Rapiti E, Fioretta G, Verkooijen HM, et al. Survival of young and older breast cancer patients in Geneva from 1990 to 2001 [J]. Eur J Cancer, 2005,41 (10):1446-1452.
  • 6廖佳建,叶长生,刘民锋,甄乐峰.青年乳腺癌Ki-67的表达及其与临床病理的关系[J].实用癌症杂志,2010,25(1):31-33. 被引量：10
  • 7施永胜,孙鑫鑫,钟献.年轻女性乳腺癌中ER、PR、HER-2和Ki67的表达与临床病理意义研究[J].中国现代医生,2012,50(36):115-116. 被引量：2
  • 8Hieken TJ, Nettnin S,Velasco JM. The value of sentinel lymph node biopsy in elderly breast cancer patients[J]. Am J Surg,2004, 188(4) :440-442.
  • 9张斌.老年人乳腺癌[J].中国癌症杂志,2005,15(5):422-425. 被引量：39
  • 10赵卫红,徐兵河,李青,张频,孙燕.70岁以上老年女性乳腺癌患者的特点和预后分析[J].中华肿瘤杂志,2006,28(5):385-388. 被引量：69

二级参考文献143

共引文献217

同被引文献12

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61 (2) :69-90.
  • 2Tolaney SM,Barry WT, Dang CT,et al. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer[J]. N Engl J Med, 2015, 372(2) : 134-141.
  • 3Rampurwala M, Wisinski KB, O'regan R. Role of the androgen receptorin triple-negative breast cancer[J]. Clin Adv Hematol 0ncol,2016,14 (3) : 186-193.
  • 4Jalava P, Kuopio T, Juntti-Patinen L, et al. Ki67 immunohistochemistry : a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index[J]. Histopathology, 2006,48 (6) : 674-682.
  • 5Bang Y J, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combina- tion with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA):a phase 3, open-label, randomised controlled trial[J]. Lancet, 2010,376 (9742) : 687-697.
  • 6Yu Q, Niu Y, Liu N, et al. Expression of androgen receptor in breast can- cer and its significance as a prognostic factor[J], Ann Oncol,2011,22 (6) : 1288-1294.
  • 7Shen H, Yang Y, Zhao L, et al. Lin28A and androgen receptor expression in ER-/Her2+ breast cancer [J]. Breast Cancer Res Treat, 2016,156 ( 1 ) : 135-147.
  • 8Peters KM ,Edwards SL,Nair SS,et al. Androgen receptor expression predicts breast cancer survival :the role of genetic and epigenetic events[J]. BMC Cancer,2012,12:132.
  • 9Gonzalez LO, Corte MD,Vazquez J, et al. Androgen receptor expresion in breast cancer:relationship with clinicopathological characteristics of the tumors,prognosis, and expression of metalloproteases and their inhibitors[J]. BMC Cancer, 2008,8 : 149.
  • 10Ni M, Chen Y, Lira E, et al. Targeting androgen receptor in estrogen reeeotor-negative breast cancer[J]. Cancer Cell, 2011,20 ( 1 ) : 119-131.

引证文献2

二级引证文献4

现代医药卫生
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部